Results 121 to 130 of about 4,058 (195)

卵巢癌患者血清ROMA、CA125、HE4联合检测的临床意义

open access: yesZhongguo shiyan zhenduanxue, 2017
卵巢癌是女性生殖系统恶性肿瘤,晚期患者5年生存率较低,预后较差[1]。目前卵巢癌的辅助诊断血清学指标常用糖类抗原125(CA125)[2],附睾蛋白4(HE4)是临床常用的另一种辅助的诊断肿瘤标记物,具有较高的特异性和敏感性[3]。卵巢恶性肿瘤风险预测值(ROMA)是近年来临床提出的一种新的预测卵巢癌的指标 ...
孔琪
doaj  

TopoIIα、GST-π、P-gp对卵巢癌患者化疗反应及预后预测的体内外实验

open access: green, 2012
Cai Hongning   +4 more
openalex   +2 more sources

β2-微球蛋白检测与卵巢癌相关性的研究

open access: yesZhongguo shiyan zhenduanxue, 2011
目的研究β2-微球蛋白在卵巢癌患者血液、尿液中的变化。方法选择在我院住院的卵巢癌组患者68例,卵巢良性肿瘤组患者65例,正常卵巢患者组60例。分别在手术前或者检查身体时抽取静脉血和留取尿液。采用免疫透射比浊法检测三组患者血液和尿液中β2-微球蛋白(β2-MG)的水平。比较卵巢癌不同分期、分级患者血/尿β2-MG的变化。结果卵巢癌患者血液中β2-MG(4.87±0.64)和尿液中β2-MG(4.86±0.72)明显高于卵巢良性肿瘤组血液中β2-MG(2.69±0.36)和尿液中β2-MG(2.73±0 ...
徐晓宏, 张伟, 王立新
doaj  

[A Transformer-based model using laboratory indicators efficiently differentiates ovarian cancer]. [PDF]

open access: yesNan Fang Yi Ke Da Xue Xue Bao
Tan S   +6 more
europepmc   +1 more source

[Development and functional validation of a nano-delivery system of miR-16/polypeptide targeting ovarian cancer cells]. [PDF]

open access: yesNan Fang Yi Ke Da Xue Xue Bao, 2021
Li Q   +8 more
europepmc   +1 more source

[WW domain-containing ubiquitin E3 ligase 1 regulates immune infiltration in tumor microenvironment of ovarian cancer]. [PDF]

open access: yesNan Fang Yi Ke Da Xue Xue Bao
Guo X   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy